4 Minute Read
This month’s market update features the latest news detailing the tumultuous relationship between pharma and 340B, including The Supreme Court, HRSA, and insight on how inflation escalates everything.
6 Minute Read
Using exclusive ICyte Benchmarks from over 230 brands across more than 50 manufacturers, we examine the top trends in specialty pharmacy contracting.
4 Minute Read
Market access leaders from DBV Technologies, Sesen Bio, and Karyopharm Therapeutics discuss strategies to overcome obstacles to patient initiation and adherence.
4 Minute Read
Expert opinions from a recent price transparency congress on reporting, remediation, and ways to manage state price transparency now and in the future.
4 Minute Read
And other industry updates including the Medi-Cal older adult expansion and profiles of new pharmacy models and 3PLs entering the market.
3 Minute Read
We recap pressing issues from the past month, including the DUNS number transition, the latest in the Eli Lilly/Streck case, and rising healthcare spending for U.S. payers.
5 Minute Read
We explore the 10 most common challenges facing Market Access operations, based on over 15 years of experience with more than 250 pharma manufacturers.
11 Minute Read
Common manufacturer concerns on best price calculations, copay accumulators and maximizers, and 340B management as the effective date for the CMS Final Rule approaches.
3 Minute Read
Regulatory Market Update Updates for Pharma Manufacturers As always, if you have questions on any of the content found in this or previous market updates, please reach out to...